ID   PGRP2_HUMAN             Reviewed;         576 AA.
AC   Q96PD5; A8K050; A8K8C7; B2RMZ2; B7ZM33; Q68CK1; Q96N74; Q9UC60;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=N-acetylmuramoyl-L-alanine amidase;
DE            EC=3.5.1.28;
DE   AltName: Full=Peptidoglycan recognition protein 2;
DE   AltName: Full=Peptidoglycan recognition protein long;
DE            Short=PGRP-L;
DE   Flags: Precursor;
GN   Name=PGLYRP2; Synonyms=PGLYRPL, PGRPL; ORFNames=UNQ3103/PRO10102;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11461926; DOI=10.1074/jbc.M105566200;
RA   Liu C., Xu Z., Gupta D., Dziarski R.;
RT   "Peptidoglycan recognition proteins: a novel family of four human
RT   innate immunity pattern recognition molecules.";
RL   J. Biol. Chem. 276:34686-34694(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-394.
RX   PubMed=15221005; DOI=10.1038/sj.onc.1207782;
RA   Yamada S., Ohira M., Horie H., Ando K., Takayasu H., Suzuki Y.,
RA   Sugano S., Hirata T., Goto T., Matsunaga T., Hiyama E., Hayashi Y.,
RA   Ando H., Suita S., Kaneko M., Sasaki F., Hashizume K., Ohnuma N.,
RA   Nakagawara A.;
RT   "Expression profiling and differential screening between
RT   hepatoblastomas and the corresponding normal livers: identification of
RT   high expression of the PLK1 oncogene as a poor-prognostic indicator of
RT   hepatoblastomas.";
RL   Oncogene 23:5901-5911(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ALA-46; GLN-99; LYS-270 AND GLN-394.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver, Mammary gland, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 22-36.
RX   PubMed=7663175; DOI=10.1006/prep.1995.1049;
RA   De Pauw P., Neyt C., Vanderwinkel E., Wattiez R., Falmagne P.;
RT   "Characterization of human serum N-acetylmuramyl-L-alanine amidase
RT   purified by affinity chromatography.";
RL   Protein Expr. Purif. 6:371-378(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF 22-36.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION AT SER-239, DEAMIDATION AT ASN-274 AND ASN-322, AND
RP   DISULFIDE BONDS.
RC   TISSUE=Liver, and Serum;
RX   PubMed=16054449; DOI=10.1016/j.bbapap.2005.07.001;
RA   Zhang Y., van der Fits L., Voerman J.S., Melief M.-J., Laman J.D.,
RA   Wang M., Wang H., Wang M., Li X., Walls C.D., Gupta D., Dziarski R.;
RT   "Identification of serum N-acetylmuramoyl-l-alanine amidase as liver
RT   peptidoglycan recognition protein 2.";
RL   Biochim. Biophys. Acta 1752:34-46(2005).
RN   [10]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   HIS-411; CYS-419; HIS-436; TRP-442 AND CYS-530.
RX   PubMed=14506276; DOI=10.1074/jbc.M307758200;
RA   Wang Z.-M., Li X., Cocklin R.R., Wang M., Wang M., Fukase K.,
RA   Inamura S., Kusumoto S., Gupta D., Dziarski R.;
RT   "Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-
RT   alanine amidase.";
RL   J. Biol. Chem. 278:49044-49052(2003).
RN   [11]
RP   GLYCOSYLATION AT ASN-485.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-77; ASN-367 AND ASN-485.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-367 AND ASN-485.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- FUNCTION: May play a scavenger role by digesting biologically
CC       active peptidoglycan (PGN) into biologically inactive fragments.
CC       Has no direct bacteriolytic activity.
CC       {ECO:0000269|PubMed:14506276}.
CC   -!- CATALYTIC ACTIVITY: Hydrolyzes the link between N-acetylmuramoyl
CC       residues and L-amino acid residues in certain cell-wall
CC       glycopeptides.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P00806};
CC   -!- SUBCELLULAR LOCATION: Secreted. Membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96PD5-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2;
CC         IsoId=Q96PD5-2; Sequence=VSP_008964;
CC         Note=May be due to an intron retention. No experimental
CC         confirmation available.;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in liver and fetal liver,
CC       and secreted into serum. Expressed to a much lesser extent in
CC       transverse colon, lymph nodes, heart, thymus, pancreas, descending
CC       colon, stomach and testis. Isoform 2 is not detected in the liver
CC       or serum. {ECO:0000269|PubMed:11461926,
CC       ECO:0000269|PubMed:16054449}.
CC   -!- SIMILARITY: Belongs to the N-acetylmuramoyl-L-alanine amidase 2
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF384856; AAL05629.1; -; mRNA.
DR   EMBL; AB073610; BAD38647.1; -; mRNA.
DR   EMBL; AY358156; AAQ88523.1; -; mRNA.
DR   EMBL; AK055882; BAB71034.1; -; mRNA.
DR   EMBL; AK289415; BAF82104.1; -; mRNA.
DR   EMBL; AK292292; BAF84981.1; -; mRNA.
DR   EMBL; CH471106; EAW84482.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84483.1; -; Genomic_DNA.
DR   EMBL; BC136551; AAI36552.1; -; mRNA.
DR   EMBL; BC136552; AAI36553.1; -; mRNA.
DR   EMBL; BC144238; AAI44239.1; -; mRNA.
DR   CCDS; CCDS12330.2; -. [Q96PD5-1]
DR   RefSeq; NP_443122.3; NM_052890.3. [Q96PD5-1]
DR   RefSeq; XP_006722696.1; XM_006722633.3. [Q96PD5-2]
DR   UniGene; Hs.282244; -.
DR   ProteinModelPortal; Q96PD5; -.
DR   SMR; Q96PD5; -.
DR   IntAct; Q96PD5; 2.
DR   STRING; 9606.ENSP00000345968; -.
DR   iPTMnet; Q96PD5; -.
DR   PhosphoSitePlus; Q96PD5; -.
DR   BioMuta; PGLYRP2; -.
DR   DMDM; 38258222; -.
DR   PaxDb; Q96PD5; -.
DR   PeptideAtlas; Q96PD5; -.
DR   PRIDE; Q96PD5; -.
DR   Ensembl; ENST00000292609; ENSP00000292609; ENSG00000161031. [Q96PD5-2]
DR   Ensembl; ENST00000340880; ENSP00000345968; ENSG00000161031. [Q96PD5-1]
DR   GeneID; 114770; -.
DR   KEGG; hsa:114770; -.
DR   UCSC; uc002nbf.5; human. [Q96PD5-1]
DR   CTD; 114770; -.
DR   DisGeNET; 114770; -.
DR   GeneCards; PGLYRP2; -.
DR   HGNC; HGNC:30013; PGLYRP2.
DR   HPA; CAB033468; -.
DR   HPA; HPA043568; -.
DR   HPA; HPA046311; -.
DR   HPA; HPA075237; -.
DR   MIM; 608199; gene.
DR   neXtProt; NX_Q96PD5; -.
DR   OpenTargets; ENSG00000161031; -.
DR   PharmGKB; PA134929965; -.
DR   eggNOG; ENOG410IIH1; Eukaryota.
DR   eggNOG; ENOG4111PAY; LUCA.
DR   GeneTree; ENSGT00390000016833; -.
DR   HOGENOM; HOG000276878; -.
DR   HOVERGEN; HBG053578; -.
DR   InParanoid; Q96PD5; -.
DR   KO; K01446; -.
DR   OMA; TEAFLGC; -.
DR   OrthoDB; EOG091G0O6Z; -.
DR   PhylomeDB; Q96PD5; -.
DR   TreeFam; TF323898; -.
DR   BRENDA; 3.5.1.28; 2681.
DR   Reactome; R-HSA-6803157; Antimicrobial peptides.
DR   GeneWiki; PGLYRP2; -.
DR   GenomeRNAi; 114770; -.
DR   PRO; PR:Q96PD5; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000161031; -.
DR   CleanEx; HS_PGLYRP2; -.
DR   ExpressionAtlas; Q96PD5; baseline and differential.
DR   Genevisible; Q96PD5; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0008745; F:N-acetylmuramoyl-L-alanine amidase activity; EXP:Reactome.
DR   GO; GO:0042834; F:peptidoglycan binding; IDA:UniProtKB.
DR   GO; GO:0016019; F:peptidoglycan receptor activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0019730; P:antimicrobial humoral response; TAS:Reactome.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0016045; P:detection of bacterium; IDA:UniProtKB.
DR   GO; GO:0044117; P:growth of symbiont in host; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; NAS:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0032827; P:negative regulation of natural killer cell differentiation involved in immune response; IEA:Ensembl.
DR   GO; GO:0001519; P:peptide amidation; NAS:UniProtKB.
DR   GO; GO:0009253; P:peptidoglycan catabolic process; IEA:InterPro.
DR   GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
DR   CDD; cd06583; PGRP; 1.
DR   Gene3D; 3.40.80.10; -; 1.
DR   InterPro; IPR002502; Amidase_domain.
DR   InterPro; IPR015510; PGRP.
DR   InterPro; IPR006619; PGRP_domain_met/bac.
DR   PANTHER; PTHR11022; PTHR11022; 1.
DR   Pfam; PF01510; Amidase_2; 1.
DR   SMART; SM00644; Ami_2; 1.
DR   SMART; SM00701; PGRP; 1.
DR   SUPFAM; SSF55846; SSF55846; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Immunity; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Secreted; Signal; Zinc.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:7663175}.
FT   CHAIN        22    576       N-acetylmuramoyl-L-alanine amidase.
FT                                /FTId=PRO_0000023920.
FT   METAL       410    410       Zinc; via pros nitrogen.
FT                                {ECO:0000250|UniProtKB:Q8INK6}.
FT   METAL       522    522       Zinc; via pros nitrogen.
FT                                {ECO:0000250|UniProtKB:Q8INK6}.
FT   METAL       530    530       Zinc. {ECO:0000250|UniProtKB:Q8INK6}.
FT   SITE        447    447       Important for catalytic activity;
FT                                essential for amidase activity and zinc
FT                                hydrate coordination.
FT                                {ECO:0000250|UniProtKB:P00806}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000269|PubMed:16054449}.
FT   MOD_RES     274    274       Deamidated asparagine.
FT                                {ECO:0000269|PubMed:16054449}.
FT   MOD_RES     322    322       Deamidated asparagine.
FT                                {ECO:0000269|PubMed:16054449}.
FT   CARBOHYD     77     77       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    367    367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    485    485       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID    419    425       {ECO:0000269|PubMed:16054449}.
FT   VAR_SEQ     548    576       TVKPRPARSVSKRSRREPPPRTLPATDLQ -> VSLRSLHY
FT                                TARRPSVYTSSTRPLPPACNSCARTASARPPTSRRHVYSGN
FT                                LGPAFAGHSAGNIPDPVTSAYAASAQPQTQPACPFPSS
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008964.
FT   VARIANT      46     46       T -> A (in dbSNP:rs3813135).
FT                                {ECO:0000269|PubMed:12975309}.
FT                                /FTId=VAR_050498.
FT   VARIANT      99     99       R -> Q (in dbSNP:rs733731).
FT                                {ECO:0000269|PubMed:12975309}.
FT                                /FTId=VAR_050499.
FT   VARIANT     257    257       T -> N (in dbSNP:rs28404490).
FT                                /FTId=VAR_050500.
FT   VARIANT     270    270       M -> K (in dbSNP:rs892145).
FT                                {ECO:0000269|PubMed:12975309}.
FT                                /FTId=VAR_050501.
FT   VARIANT     394    394       R -> Q (in dbSNP:rs34440547).
FT                                {ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:15221005}.
FT                                /FTId=VAR_055231.
FT   VARIANT     476    476       R -> W (in dbSNP:rs2304200).
FT                                /FTId=VAR_050502.
FT   MUTAGEN     411    411       H->A: No effect on amidase activity.
FT                                {ECO:0000269|PubMed:14506276}.
FT   MUTAGEN     419    419       C->A: Abolishes amidase activity.
FT                                {ECO:0000269|PubMed:14506276}.
FT   MUTAGEN     436    436       H->A: No effect on amidase activity.
FT                                {ECO:0000269|PubMed:14506276}.
FT   MUTAGEN     442    442       W->A: Reduced amidase activity.
FT                                {ECO:0000269|PubMed:14506276}.
FT   MUTAGEN     447    447       Y->A: Abolishes amidase activity.
FT   MUTAGEN     530    530       C->S: Abolishes amidase activity.
FT                                {ECO:0000269|PubMed:14506276}.
FT   CONFLICT    124    124       L -> P (in Ref. 6; AAI44239).
FT                                {ECO:0000305}.
FT   CONFLICT    448    448       S -> G (in Ref. 4; BAB71034).
FT                                {ECO:0000305}.
FT   CONFLICT    562    562       R -> G (in Ref. 4; BAF82104).
FT                                {ECO:0000305}.
SQ   SEQUENCE   576 AA;  62217 MW;  73EA8713DC54F85A CRC64;
     MAQGVLWILL GLLLWSDPGT ASLPLLMDSV IQALAELEQK VPAAKTRHTA SAWLMSAPNS
     GPHNRLYHFL LGAWSLNATE LDPCPLSPEL LGLTKEVARH DVREGKEYGV VLAPDGSTVA
     VEPLLAGLEA GLQGRRVINL PLDSMAAPWE TGDTFPDVVA IAPDVRATSS PGLRDGSPDV
     TTADIGANTP DATKGCPDVQ ASLPDAKAKS PPTMVDSLLA VTLAGNLGLT FLRGSQTQSH
     PDLGTEGCWD QLSAPRTFTL LDPKASLLTM AFLNGALDGV ILGDYLSRTP EPRPSLSHLL
     SQYYGAGVAR DPGFRSNFRR QNGAALTSAS ILAQQVWGTL VLLQRLEPVH LQLQCMSQEQ
     LAQVAANATK EFTEAFLGCP AIHPRCRWGA APYRGRPKLL QLPLGFLYVH HTYVPAPPCT
     DFTRCAANMR SMQRYHQDTQ GWGDIGYSFV VGSDGYVYEG RGWHWVGAHT LGHNSRGFGV
     AIVGNYTAAL PTEAALRTVR DTLPSCAVRA GLLRPDYALL GHRQLVRTDC PGDALFDLLR
     TWPHFTATVK PRPARSVSKR SRREPPPRTL PATDLQ
//
